Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$56.88

0.24 (0.42%)

07:04
07/19/18
07/19
07:04
07/19/18
07:04

Bristol-Myers announces research collaboration with Gritstone Oncology

Bristol-Myers and Gritstone Oncology announced that the companies have entered into a clinical trial collaboration to evaluate the safety and tolerability of Gritstone's personalized neoantigen immunotherapy, GRANITE-001, which comprises sequential delivery of neoantigens to patients within an adenovirus-based vector and a self-replicating RNA-based vector, in combination with Bristol-Myers Squibb's programmed death-1 immune checkpoint inhibitor, Opdivo and Opdivo plus Yervoy, in patients with advanced solid tumors. The two-part Phase 1 dose escalation trial, which is anticipated to be initiated before the end of 2018, will evaluate the combination of GRANITE-001 with systemic Opdivo, and a localized subcutaneous injection of Yervoy. Subcutaneous administration of Yervoy is intended to maximize delivery of drug to the immunotherapy-draining lymph node.

BMY Bristol-Myers
$56.88

0.24 (0.42%)

06/13/18
MSCO
06/13/18
NO CHANGE
MSCO
HHS 'smoke signals' worth noting for drugmakers, says Morgan Stanley
After HHS Secretary Alex Azar spoke at a two-hour Senate hearing, Morgan Stanley analyst David Risinger noted that Azar suggested that U.S. drug pricing needs to move to a system without rebates and said payments from drugmakers to PBMs should be eliminated. In listing four HHS actions that could hurt manufacturers, Risinger pointed out that Azar said he is interested in removing 100% cap on Medicaid rebates; he would like to adjust the Part D protected drug classes so that plans can extract rebates from manufacturers; HHS wants to require manufacturers to disclose drug list prices in TV ads; and HHS is focused on transitioning Part B to lower-priced private sector management. In summary, the analyst said that for drugmakers there was "no fire, but smoke signals worth noting." Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
06/19/18
06/19/18
DOWNGRADE
Target $300

In Line
Madrigal cut to In Line at Evercore ISI following run-up in price, expectations
As previously reported, Evercore ISI analyst Josh Schimmer downgraded Madrigal Pharmaceuticals (MDGL) to In Line from Outperform, stating that he has no real incremental reason to raise his $300 price target, which the stock has achieved following the company's encouraging Phase 2 results for MGL-3196 and a Bloomberg report that has driven takeover speculation. Given current investor sentiment, anything short of either an acquisition or a "massive" collaboration like Bristol-Myers' (BMY) with Nektar (NKTR) will fall short of expectations, Schimmer tells investors.
06/28/18
WELS
06/28/18
NO CHANGE
WELS
Wells says Amazon deal, Walgreens results have negative read for drug pricing
After Amazon (AMZN) agreed to acquire online pharmacy PillPack, reportedly for $1B, Wells Fargo analyst David Maris noted that he has long stated that Amazon would enter the pharmacy business and warned about the risk to drug pricing in such a scenario. Maris also noted that Walgreens (WBA) reported its U.S. retail pharmacy comparable store sales fell 1.2% in Q3, adding that retailers tend to push drugmakers on price when they feel pressure and the read-through from its report may be negative for drug pricing. Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/11/18
WELS
07/11/18
NO CHANGE
WELS
Drug stocks may not react favorably to Pfizer price rollback, Trump tweets, says Wells Fargo
Wells Fargo analyst David Maris notes that there was widespread media coverage of drug price increases taken recently by several large cap drug companies, with President Trump criticizing Pfizer (PFE) for taking these price increases. On Tuesday, Pfizer confirmed it was rolling back its July drug price increases following a conversation with President Trump, he adds. Maris believes that drug stocks will not react favorably to this news, given the chilling effect this will likely have on others looking to take price increases. Nonetheless, the analyst points out that the price increases taken in July are only a small number of increases taken over the past year or several years, so the impact of the rollback to the healthcare system is insignificant in the big picture. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).

TODAY'S FREE FLY STORIES

NKE

Nike

$83.11

-1.44 (-1.70%)

, ADDYY

Adidas

$0.00

(0.00%)

11:36
05/20/19
05/20
11:36
05/20/19
11:36
Periodicals
Shoe retailers urge Trump to halt raising tariffs on footwear, CNBC reports »

Over 170 shoe retailers…

NKE

Nike

$83.11

-1.44 (-1.70%)

ADDYY

Adidas

$0.00

(0.00%)

FL

Foot Locker

$54.40

-0.83 (-1.50%)

UAA

Under Armour

$23.61

-0.04 (-0.17%)

UA

Under Armour

$20.76

0.05 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 06

    Jun

  • 09

    Jul

11:36
05/20/19
05/20
11:36
05/20/19
11:36
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:36
05/20/19
05/20
11:36
05/20/19
11:36
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

GM

General Motors

$36.74

-0.26 (-0.70%)

11:30
05/20/19
05/20
11:30
05/20/19
11:30
Options
Giant call buy in GM »

Giant call buy in GM.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

  • 05

    Jun

  • 01

    Aug

CNC

Centene

$56.12

0.1 (0.18%)

11:27
05/20/19
05/20
11:27
05/20/19
11:27
Options
Size call buy in Centene »

Size call buy in Centene.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 14

    Jun

  • 23

    Jul

NXPI

NXP Semiconductors

$92.19

-2.93 (-3.08%)

11:26
05/20/19
05/20
11:26
05/20/19
11:26
Options
- Bullish option flow detected in NXP Semiconductors with 7,412 calls »

- Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 13

    Jun

NXPI

NXP Semiconductors

$91.93

-3.19 (-3.35%)

11:25
05/20/19
05/20
11:25
05/20/19
11:25
Options
NXP Semiconductors call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 13

    Jun

AJG

Arthur J. Gallagher

$83.41

0.05 (0.06%)

, BRO

Brown & Brown

$31.71

0.02 (0.06%)

11:25
05/20/19
05/20
11:25
05/20/19
11:25
Conference/Events
William Blair insurance analyst to hold a luncheon meeting »

Insurance Analyst Klauber…

AJG

Arthur J. Gallagher

$83.41

0.05 (0.06%)

BRO

Brown & Brown

$31.71

0.02 (0.06%)

MMC

Marsh & McLennan

$95.95

0.16 (0.17%)

AON

Aon plc

$179.99

-0.57 (-0.32%)

WLTW

Willis Towers Watson

$175.98

-0.04 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 11

    Jun

  • 19

    Jun

MRK

Merck

$78.94

0.225 (0.29%)

11:22
05/20/19
05/20
11:22
05/20/19
11:22
Periodicals
Supreme Court throws out rulling against Merck on Fosamax, Reuters reports »

The U.S. Supreme Court…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 31

    May

  • 03

    Jun

  • 17

    Jun

  • 20

    Jun

  • 20

    Jun

  • 16

    Jul

  • 30

    Jul

  • 06

    Aug

  • 20

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
05/20/19
05/20
11:17
05/20/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$31.19

-4.14 (-11.72%)

, SATS

EchoStar

$42.01

1.59 (3.93%)

11:16
05/20/19
05/20
11:16
05/20/19
11:16
Downgrade
Dish, EchoStar, Sprint, T-Mobile rating change  »

Dish downgraded to Hold…

DISH

Dish

$31.19

-4.14 (-11.72%)

SATS

EchoStar

$42.01

1.59 (3.93%)

S

Sprint

$7.73

1.55 (25.10%)

TMUS

T-Mobile

$79.92

4.53 (6.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
05/20/19
05/20
11:16
05/20/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/20/19
05/20
11:15
05/20/19
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
05/20/19
05/20
11:15
05/20/19
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

TILE

Interface

$15.74

-0.28 (-1.75%)

11:10
05/20/19
05/20
11:10
05/20/19
11:10
Conference/Events
Interface management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 21

    May

GM

General Motors

$36.81

-0.19 (-0.51%)

11:07
05/20/19
05/20
11:07
05/20/19
11:07
Hot Stocks
General Motors unveils new electronic platform »

General Motors announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 04

    Jun

  • 05

    Jun

  • 01

    Aug

DISH

Dish

$31.11

-4.22 (-11.94%)

11:06
05/20/19
05/20
11:06
05/20/19
11:06
Downgrade
Dish rating change  »

Dish downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZVO

Zovio

$4.66

-0.05 (-1.06%)

10:57
05/20/19
05/20
10:57
05/20/19
10:57
Conference/Events
Zovio management to meet with Barrington »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 10

    Jun

  • 11

    Jun

LOW

Lowe's

$108.61

-0.39 (-0.36%)

, HD

Home Depot

$192.49

-0.04 (-0.02%)

10:31
05/20/19
05/20
10:31
05/20/19
10:31
On The Fly
Fly Intel: What to watch in Home Depot, Lowe's earnings reports »

Home improvement…

LOW

Lowe's

$108.61

-0.39 (-0.36%)

HD

Home Depot

$192.49

-0.04 (-0.02%)

AMZN

Amazon.com

$1,851.99

-16.33 (-0.87%)

SHLD

Sears

$0.00

(0.00%)

JCP

J.C. Penney

$1.11

-0.035 (-3.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 24

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 24

    Jun

TSLA

Tesla

$199.00

-12.02 (-5.70%)

, TROW

T. Rowe Price

$103.87

-0.55 (-0.53%)

10:31
05/20/19
05/20
10:31
05/20/19
10:31
On The Fly
Tesla dips below $200 as analysts voice concern over Model 3 demand »

Shares of Tesla (TSLA)…

TSLA

Tesla

$199.00

-12.02 (-5.70%)

TROW

T. Rowe Price

$103.87

-0.55 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

VRNA

Verona Pharma

$5.90

-0.45 (-7.09%)

10:20
05/20/19
05/20
10:20
05/20/19
10:20
Hot Stocks
Verona Pharma presents expanded analysis of ensifentrine clinical data »

Verona Pharma presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$19.26

-0.38 (-1.93%)

, TBPH

Theravance Biopharma

$20.19

-0.44 (-2.13%)

10:19
05/20/19
05/20
10:19
05/20/19
10:19
Hot Stocks
Theravance, Mylan study highlights possible role of Yupelri in COPD treatment »

Theravance Biopharma…

MYL

Mylan

$19.26

-0.38 (-1.93%)

TBPH

Theravance Biopharma

$20.19

-0.44 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

10:19
05/20/19
05/20
10:19
05/20/19
10:19
Conference/Events
Wolfe Research IT hardware analyst to hold an analyst/industry conference call »

IT Hardware &…

GOOS

Canada Goose

$47.69

-0.65 (-1.34%)

, OSW

OneSpaWorld

$13.55

0.05 (0.37%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

GOOS

Canada Goose

$47.69

-0.65 (-1.34%)

OSW

OneSpaWorld

$13.55

0.05 (0.37%)

ZM

Zoom Video

$86.55

-3.36 (-3.74%)

BYND

Beyond Meat

$88.70

-0.63 (-0.71%)

FMC

FMC Corporation

$74.01

-1.24 (-1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 06

    Jun

AAL

American Airlines

$30.38

-1.38 (-4.35%)

, DAL

Delta Air Lines

$54.07

-0.82 (-1.49%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

AAL

American Airlines

$30.38

-1.38 (-4.35%)

DAL

Delta Air Lines

$54.07

-0.82 (-1.49%)

DB

Deutsche Bank

$7.42

-0.16 (-2.11%)

EV

Eaton Vance

$36.91

-0.895 (-2.37%)

PRA

ProAssurance

$38.42

-0.72 (-1.84%)

CLX

Clorox

$147.09

0.03 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 12

    Jun

  • 12

    Jun

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.